Alembic Pharma gets USFDA nod for its antibiotic capsules

The approval from USFDA is for the company's abbreviated new drug application (ANDA) in the strengths of 50 mg and 100 mg, Alembic Pharma said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news